Business

RIS Rx Appoints Stuart McGuigan to Board of Directors

IRVINE, Calif., December 17, 2025--RIS Rx, a healthcare technology company offering gross-to-net (GTN) revenue protection and saving more than $1 billion for the world’s leading pharmaceutical manufacturers, today announced the appointment of Stuart McGuigan to its Board of Directors.

articleFresenius Medical Care AgDecember 17, 20252/company/fresenius-medical-care-ag-and-co-kgaa/news/ris-rx-appoints-stuart-mcguigan-to-board-of-directors
RIS Rx Appoints Stuart McGuigan to Board of Directors

About this update from Fresenius Medical Care Ag

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":600,"height":210,"url":"https://media.zenfs.com/en/business-wire.com/63a645f245f27271b52bc73d21f4c22c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/5.hdy3gA81rLZHvcv15VCg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMzNjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/63a645f245f27271b52bc73d21f4c22c","width":600,"height":210}},"lazy":false},{"type":"text","content":"IRVINE, Calif., December 17, 2025--(BUSINESS WIRE)--RIS Rx, a healthcare technology company offering gross-to-net (GTN) revenue protection and saving more than $1 billion for the world’s leading pharmaceutical manufacturers, today announced the appointment of Stuart McGuigan to its Board of Directors.","length":302,"tagName":"p"},{"type":"text","content":"Mr. McGuigan is an expert technology and healthcare executive with more than three decades of experience driving digital transformation and operational excellence in complex global organizations. Most recently, he served as Interim Global Chief Information Officer for Fresenius Medical Care, where he oversaw technology strategy and execution across the company’s global dialysis and renal care operations. Prior to this role, Mr. McGuigan was Chief Information Officer of the U.S. Department of State, where he established strategic direction and provided oversight for multibillion-dollar technology programs. Prior to that, he led global information technology for Johnson & Johnson and held senior technology leadership roles at CVS Caremark, Liberty Mutual and Medco Health Solutions. Mr. McGuigan also serves on multiple boards, including Enhabit Home Health & Hospice, American Water and Fairfield University’s John Charles Meditz College of Arts and Sciences, and he is widely recognized for aligning technology innovation with organizational strategy to drive measurable business results.","length":1106,"tagName":"p"},{"type":"text","content":""RIS Rx’s mission to bring transparency and accountability to the GTN process is vital to advancing patient access," said Gerard Rivera, CEO and Co-Founder of RIS Rx. "Stuart’s deep expertise in technology innovation and strategic leadership across healthcare and global enterprises will be an invaluable asset as we continue to...

More updates from Fresenius Medical Care Ag

RISStuart McGuiganpharmaceutical manufacturersMcGuiganFresenius Medical Caretechnology strategytechnology innovationMedco Health Solutionsrevenue protectionhealthcare technology